Image
02.04.2024
44 years of being supported by Diabetes UK: Lynette is doing Swim 22 t...
Lynette Cockburn from Birmingham is doing Swim 22 (11 miles option) to raise money and awareness of diabe...
customer support
customer support
From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.
Read more